Form 4 for TENX TENAX THERAPEUTICS, INC.

Accepted 2025-11-20 00:00:00 ET · period of report 2025-11-18 · accession 0001871714-25-000002 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2025-11-20	2025-11-18+	TENX	Giordano Christopher Thomas	CEO, Dir	P - Purchase	$7.68	+2,605	1,612	New	+$20.0K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2025-11-19	P	A	455	$7.51	2,067	D	—	—	(F2) This transaction was executed in multiple trades at prices ranging from $7.35 to $7.62. The price reported in Column 4 is a weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
2	Common	Common Stock	2025-11-20	P	A	538	$7.59	2,605	D	—	—	(F3) This transaction was executed in multiple trades at prices ranging from $7.54 to $7.73. The price reported in Column 4 is a weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
3	Common	Common Stock	2025-11-18	P	A	1,612	$7.75	1,612	D	—	—	(F1) This transaction was executed in multiple trades at prices ranging from $7.47 to $7.68. The price reported in Column 4 is a weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.